市場調查報告書

全球視網膜疾病治療市場:疾病適應症,治療水準,劑型,流通管道,及各地區預測

Global Retinal Disorder Treatment Market Size study, by Disease Indication, by Therapeutic Class, by Dosage Form, by Distribution Channel and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 923399
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球視網膜疾病治療市場:疾病適應症,治療水準,劑型,流通管道,及各地區預測 Global Retinal Disorder Treatment Market Size study, by Disease Indication, by Therapeutic Class, by Dosage Form, by Distribution Channel and Regional Forecasts 2019-2026
出版日期: 2020年01月20日內容資訊: 英文
簡介

本報告提供全球視網膜疾病治療市場的相關調查,提供市場機會,課題及趨勢,成長要素,疾病適應症·治療水準·劑型·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 市場估計及預測:世界/各市場區隔
  • 主要趨勢
  • 估計方法
  • 調查的前提條件

第2章 市場定義及範圍

  • 調查的目的
  • 市場定義·範圍
    • 調查範圍
    • 產業的發展
  • 研究涵蓋年份
  • 匯率

第3章 市場動態

  • 市場影響分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的建議·結論

第5章 市場分析:各疾病適應症

  • 市場概述
  • 市場實際成果:潛在力分析
  • 市場估計·預測
  • 子區隔分析
    • 黃斑部病變
    • 糖尿病視網膜病變
    • 糖尿病黃斑部水腫
    • 其他(視網膜靜脈阻塞等)

第6章 市場分析:各治療水準

  • 市場概述
  • 市場實際成果:潛在力分析
  • 市場估計·預測
  • 子區隔分析
    • 抗VEGF劑
    • 其他(抗發炎藥等)

第7章 市場分析:各劑型

  • 市場概述
  • 市場實際成果:潛在力分析
  • 市場估計·預測
  • 子區隔分析
    • 凝膠
    • 眼藥水
    • 膠囊·錠劑
    • 眼科用藥
    • 軟膏

第8章 市場分析:各流通管道

  • 市場概述
  • 市場實際成果:潛在力分析
  • 市場估計·預測
  • 子區隔分析
    • 醫院藥局
    • 零售藥局
    • 線上銷售

第9章 市場分析:各地區

  • 市場概述
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第10章 競爭情形

  • 主要市場策略
  • 企業簡介
    • 參天製藥株式會社
    • Regeneron Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Pfizer, Inc.
    • Allergan plc
    • Shire (武田藥品工業株式會社)
    • Bayer AG
    • Graybug Vision, Inc.
    • Novartis AG
    • Acucela Inc. (窪田製藥集團株式會社)

第11章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 調查屬性
  • 調查的前提條件
目錄

Global Retinal Disorder Treatment Market is valued approximately at USD 8.73 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2019-2026. Retina is a thin membranous lining at the back of the eye. It is a light sensitive nerve tissue on which the images focused and converted into electrical impulses which are carried to the brain via optic nerve. Retinal disorders affect the important tissues of the eye and can even cause temporary to permanent blindness. According to World Health Organization 2019, over 295 million people are visually impaired worldwide of which 39 million are blind. Further, retinal diseases are the most common cause of childhood blindness across the globe. Some of these children are blinded by inherited retinal diseases (IRD) like retinitis pigmentosa (incurable) while many of them can have retinopathy of prematurity (curable). Growing retinal diseases worldwide calls for the need of affordable and effective treatment alternatives which in turn will drive the global retinal disorder treatment market. Also, technical advancements, new product launches, collaborations and other strategies being executed by the major players is anticipated to provide low cost and effective retinal disorder treatment and hence fuel the market growth. Moreover, government and other nonprofit organizations are increasing spending on the treatment of retinal disorder treatments. For instance, The Foundation Fighting Blindness, a nonprofit organization established on 1971, is leading a collaborative effort among scientists, patients, their families and the commercial sector to propel the development of preventions, treatments, and cures for inherited retinal diseases (IRDs). Therefore, rising awareness, collaborative efforts and initiatives by the key players are the factors likely to create growth opportunities to the retinal disorder treatment market over the forecast period.

The regional analysis of global Retinal Disorder Treatment Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of key market players in the region. Also, increasing prevalence of retinal disorders is expected to fuel the regional growth. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about early diagnosis, high unmet clinical needs and availability of effective treatment methods are responsible for the high CAGR of the region over the forecast period.

Major market player included in this report are:

Santen Pharmaceutical Co., Ltd.

Regeneron Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd.

Pfizer, Inc.

Allergan plc

Shire (Takeda Pharmaceutical Company Limited)

Bayer AG

Graybug Vision, Inc.

Novartis AG

Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

Macular Degeneration

Diabetic Retinopathy

Diabetic Macular Edema

Others (Retinal Vein Occlusion, etc.)

By Therapeutic Class:

Anti-VEGF Agents

Others (Anti-inflammatory Drugs, etc.)

By Dosage Form:

Gels

Eye Solutions

Capsules & Tablets

Eye Drops

Ointments

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Sales

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Retinal Disorder Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Retinal Disorder Treatment Market, by Disease Indication, 2017-2026 (USD Billion)
    • 1.2.2. Retinal Disorder Treatment Market, by Therapeutic Class, 2017-2026 (USD Billion)
    • 1.2.3. Retinal Disorder Treatment Market, by Dosage Form, 2017-2026 (USD Billion)
    • 1.2.4. Retinal Disorder Treatment Market, by Distribution Channel, 2017-2026 (USD Billion)
    • 1.2.5. Retinal Disorder Treatment Market, by Region, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Retinal Disorder Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Retinal Disorder Treatment Market Dynamics

  • 3.1. Retinal Disorder Treatment Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Retinal Disorder Treatment Market Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Retinal Disorder Treatment Market, by Disease Indication

  • 5.1. Market Snapshot
  • 5.2. Global Retinal Disorder Treatment Market by Disease Indication, Performance - Potential Analysis
  • 5.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Disease Indication 2016-2026 (USD Billion)
  • 5.4. Retinal Disorder Treatment Market, Sub Segment Analysis
    • 5.4.1. Macular Degeneration
    • 5.4.2. Diabetic Retinopathy
    • 5.4.3. Diabetic Macular Edema
    • 5.4.4. Others (Retinal Vein Occlusion, etc.)

Chapter 6. Global Retinal Disorder Treatment Market, by Therapeutic Class

  • 6.1. Market Snapshot
  • 6.2. Global Retinal Disorder Treatment Market by Therapeutic Class, Performance - Potential Analysis
  • 6.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Therapeutic Class, 2016-2026 (USD Billion)
  • 6.4. Retinal Disorder Treatment Market, Sub Segment Analysis
    • 6.4.1. Anti-VEGF Agents
    • 6.4.2. Others (Anti-inflammatory Drugs, etc.)

Chapter 7. Global Retinal Disorder Treatment Market, by Dosage Form

  • 7.1. Market Snapshot
  • 7.2. Global Retinal Disorder Treatment Market by Dosage Form, Performance - Potential Analysis
  • 7.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Dosage Form, 2016-2026 (USD Billion)
  • 7.4. Retinal Disorder Treatment Market, Sub Segment Analysis
    • 7.4.1. Gels
    • 7.4.2. Eye Solutions
    • 7.4.3. Capsules & Tablets
    • 7.4.4. Eye Drops
    • 7.4.5. Ointments

Chapter 8. Global Retinal Disorder Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Retinal Disorder Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Distribution Channel, 2016-2026 (USD Billion)
  • 8.4. Retinal Disorder Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Sales

Chapter 9. Global Retinal Disorder Treatment Market, Regional Analysis

  • 9.1. Retinal Disorder Treatment Market, Regional Market Snapshot
  • 9.2. North America Retinal Disorder Treatment Market
    • 9.2.1. U.S. Retinal Disorder Treatment Market
      • 9.2.1.1. Disease Indication breakdown estimates & forecasts, 2016-2026
      • 9.2.1.2. Therapeutic Class breakdown estimates & forecasts, 2016-2026
      • 9.2.1.3. Dosage Form breakdown estimates & forecasts, 2016-2026
      • 9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026
    • 9.2.2. Canada Retinal Disorder Treatment Market
  • 9.3. Europe Retinal Disorder Treatment Market Snapshot
    • 9.3.1. U.K. Retinal Disorder Treatment Market
    • 9.3.2. Germany Retinal Disorder Treatment Market
    • 9.3.3. Rest of Europe Retinal Disorder Treatment Market
  • 9.4. Asia-Pacific Retinal Disorder Treatment Market Snapshot
    • 9.4.1. China Retinal Disorder Treatment Market
    • 9.4.2. India Retinal Disorder Treatment Market
    • 9.4.3. Japan Retinal Disorder Treatment Market
    • 9.4.4. Rest of Asia Pacific Retinal Disorder Treatment Market
  • 9.5. Latin America Retinal Disorder Treatment Market Snapshot
    • 9.5.1. Brazil Retinal Disorder Treatment Market
    • 9.5.2. Mexico Retinal Disorder Treatment Market
  • 9.6. Rest of The World Retinal Disorder Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Santen Pharmaceutical Co., Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject To Data Availability)
      • 10.2.1.4. Sensor Type Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Regeneron Pharmaceuticals, Inc.
    • 10.2.3. F. Hoffmann-La Roche Ltd.
    • 10.2.4. Pfizer, Inc.
    • 10.2.5. Allergan plc
    • 10.2.6. Shire (Takeda Pharmaceutical Company Limited)
    • 10.2.7. Bayer AG
    • 10.2.8. Graybug Vision, Inc.
    • 10.2.9. Novartis AG
    • 10.2.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET
  • TABLE 2. LIST OF PRIMARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET
  • TABLE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISEASE INDICATION 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY THERAPEUTIC CLASS 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 27. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 50. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 59. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 62. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL RETINAL DISORDER TREATMENT MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL RETINAL DISORDER TREATMENT MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL RETINAL DISORDER TREATMENT MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL RETINAL DISORDER TREATMENT MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL RETINAL DISORDER TREATMENT MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL RETINAL DISORDER TREATMENT MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL RETINAL DISORDER TREATMENT MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 10. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 11. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 12. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 13. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 14. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 15. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, 2016-2026 (USD BILLION)
  • FIG 16. GLOBAL RETINAL DISORDER TREATMENT MARKET, REGIONAL SNAPSHOT 2016-2026
  • FIG 17. NORTH AMERICA RETINAL DISORDER TREATMENT MARKET 2016-2026 (USD BILLION)
  • FIG 18. EUROPE RETINAL DISORDER TREATMENT MARKET 2016-2026 (USD BILLION)
  • FIG 19. ASIA PACIFIC RETINAL DISORDER TREATMENT MARKET 2016-2026 (USD BILLION)
  • FIG 20. LATIN AMERICA RETINAL DISORDER TREATMENT MARKET 2016-2026 (USD BILLION)
  • FIG 21. GLOBAL RETINAL DISORDER TREATMENT MARKET, COMPANY MARKET SHARE ANALYSIS (2018)